Clinical Trial Update: Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating safety and efficacy of NTCELL immunoprotected porcine choroid plexus cells for xenotransplantation in Parkinson's Disease has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NTCELL (Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells)

Snippet

Sponsor: Living Cell Technologies | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED